Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience

Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience

Bibliographic Details
Main Author:	Sean P. Elliott
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2009-12-01
Series:	International Brazilian Journal of Urology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382009000600023

Similar Items

Integrative Medicine Program- MD Anderson Cancer Center
by: Richard T Lee
Published: (2012-06-01)

Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience
by: Henry J. Conter, et al.
Published: (2014-01-01)

Changes in lower urinary tract symptoms after prostate brachytherapy
by: Bruce L. Jacobs, et al.
Published: (2011-09-01)

Portuguese validation of the Symptom Inventory of the M.D. Anderson Cancer Center
by: Adriane Cristina Bernat Kolankiewicz, et al.
Published: (2014-12-01)

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience
by: Nidale Tarek, et al.
Published: (2020-10-01)

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
by: Philipp Maletzki, et al.
Published: (2018-06-01)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
by: Du E, et al.
Published: (2017-05-01)

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
by: Kenta Onishi, et al.
Published: (2019-01-01)

Calculation of Changes in RadiationExposure due to Prostate Displacement inPermanent Prostate Brachytherapy
by: Zahra Siavashpour, et al.
Published: (2010-07-01)

Implementation and assessment of bi-radionuclide seeds for permanent implant prostate brachytherapy
by: Nuttens, Vincent E
Published: (2008)

The life and professional contributions of William Gilbert Anderson, M.D. /
by: Ray, Harold Lloyd
Published: (1959)

Prostate cancer brachytherapy. Experience of the branches of the National Medical Research Center of Radiology
by: A. D. Kaprin, et al.
Published: (2018-04-01)

Experimental Method Development for Direct Dosimetry of Permanent Interstitial Prostate Brachytherapy Implants
by: Jarrett, John Michael
Published: (2005)

First experience of salvage HDR brachytherapy after prostate cancer radiotherapy
by: Juras Kišonas, et al.
Published: (2015-03-01)

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
by: Mehmet Altan, et al.
Published: (2020-07-01)

Radiation-Induced Leiomyosarcoma of the Prostate after Brachytherapy for Prostatic Adenocarcinoma
by: Hiroto Horiguchi, et al.
Published: (2014-08-01)

Prostate brachytherapy in Ghana: our initial experience
by: James Edward Mensah, et al.
Published: (2016-10-01)

Comparative analysis of international prognostic index for chronic lymphocytic leukemia, progression-risk score, and MD Anderson Cancer Center 2011 score - a single center experience
by: Mihaljević Biljana, et al.
Published: (2021-01-01)

Prospective trial comparing intraoperative flexible, rigid, and no cystoscopy after ultrasound-guided transperineal permanent seed prostate brachytherapy
by: John Sylvester, et al.
Published: (2016-06-01)

Brachytherapy for Prostate Cancer
by: Wirth, Manfred P., et al.
Published: (2014)

Evaluation of transrectal ultrasound-based dosimetry for brachytherapy of prostate cancer: a single-center experience
by: Changzhao Yang, et al.
Published: (2020-08-01)

Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion
by: M. Sean Peach, et al.
Published: (2016-01-01)

Migration of the prostate brachytherapy seeds into urinary bladder with stone formation: A case report
by: Chung-Tso Chen, et al.
Published: (2021-08-01)

Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials
by: Gregory S. Merrick, et al.
Published: (2017-10-01)

Comparison of prostate contours between conventional stepping transverse imaging and Twister-based sagittal imaging in permanent interstitial prostate brachytherapy
by: Shogo Kawakami, et al.
Published: (2017-08-01)

Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy
by: Masahiro Inada, et al.
Published: (2017-10-01)

Dosimetry of permanent interstitial prostate brachytherapy for an intraoperative procedure, using O-arm based CT and TRUS
by: Hiromichi Ishiyama, et al.
Published: (2016-02-01)

Photoacoustic imaging for prostate brachytherapy
by: Pan, Leo Lijia
Published: (2014)

Individual estimation of the level of prostatic specific antigen in patients with prostate cancer after brachytherapy
by: N. G. Minayeva, et al.
Published: (2020-02-01)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
by: John M. Lacy, et al.
Published: (2016-01-01)

MD Anderson Dysphagia Questionnaire: Tradução e adaptação cultural para o português europeu
by: Cátia Alexandra Dias Bastos
Published: (2019)

Quantitative techniques for permanent breast seed implant brachytherapy
by: Morton, Daniel R.
Published: (2017)

Long-term tumor control after brachytherapy for base-of-prostate cancer
by: Seungtaek Choi, et al.
Published: (2011-12-01)

Thirty-day hospital revisits after prostate brachytherapy: who is at risk?
by: Belinda Li, et al.
Published: (2019-06-01)

Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.
by: Laura L Michel, et al.
Published: (2019-01-01)

Prostate brachytherapy: HDR or seed implant
by: Das K
Published: (2006-01-01)

Information fusion for prostate brachytherapy planning
by: Nouranian, Saman
Published: (2016)

Permanent <sup>125</sup>I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
by: Mazeron Renaud, et al.
Published: (2012-03-01)

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
by: Yinghong Wang, et al.
Published: (2018-05-01)

Validation of the Spanish version of the MD Anderson symptom inventory – heart failure (MDASI-HF-Spanish) module
by: Anecita Fadol, et al.
Published: (2019-12-01)